Alnylam Pharmaceuticals
ALNY
#788
Rank
HK$244.32 B
Marketcap
HK$1,826
Share price
3.63%
Change (1 day)
-49.05%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company